Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The Impact of Pancreatic Head Resection on Blood Glucose Homeostasis in Patients with Chronic Pancreatitis

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      TU Dresden
    • Publication Information:
      MDPI
    • Publication Date:
      2022
    • Collection:
      Dresden University of Technology: Qucosa
    • Abstract:
      Background: Chronic pancreatitis (CP) often leads to recurrent pain as well as exocrine and/or endocrine pancreatic insufficiency. This study aimed to investigate the effect of pancreatic head resections on glucose metabolism in patients with CP. Methods: Patients who underwent pylorus-preserving pancreaticoduodenectomy (PPPD), Whipple procedure (cPD), or duodenum-preserving pancreatic head resection (DPPHR) for CP between January 2011 and December 2020 were retrospectively analyzed with regard to markers of pancreatic endocrine function including steady-state beta cell function (%B), insulin resistance (IR), and insulin sensitivity (%S) according to the updated Homeostasis Model Assessment (HOMA2). Results: Out of 141 pancreatic resections for CP, 43 cases including 31 PPPD, 2 cPD and 10 DPPHR, met the inclusion criteria. Preoperatively, six patients (14%) were normoglycemic (NG), 10 patients (23.2%) had impaired glucose tolerance (IGT) and 27 patients (62.8%) had diabetes mellitus (DM). In each subgroup, no significant changes were observed for HOMA2-%B (NG: p = 0.57; IGT: p = 0.38; DM: p = 0.1), HOMA2-IR (NG: p = 0.41; IGT: p = 0.61; DM: p = 0.18) or HOMA2-%S (NG: p = 0.44; IGT: p = 0.52; DM: p = 0.51) 3 and 12 months after surgery, respectively. Conclusion: Pancreatic head resections for CP, including DPPHR and pancreatoduodenectomies, do not significantly affect glucose metabolism within a follow-up period of 12 months.
    • ISSN:
      2077-0383
    • Relation:
      663; info:eu-repo/grantAgreement/European Commission/H2020 %7C IMI2-RIA/115881 //Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification/RHAPSODY; info:eu-repo/grantAgreement/European Commission/H2020 %7C IMI2-RIA/115797 //Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes/INNODIA; https://tud.qucosa.de/id/qucosa%3A86842
    • Online Access:
      https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-868423
      https://tud.qucosa.de/id/qucosa%3A86842
      https://tud.qucosa.de/api/qucosa%3A86842/attachment/ATT-0/
    • Rights:
      info:eu-repo/semantics/openAccess
    • Accession Number:
      edsbas.B4A28107